Paracetamol (Acetaminophen): Maximum Daily Dose, the Liver and Alcohol

At therapeutic doses most paracetamol is converted in the liver into harmless conjugates (glucuronides and sulphates) that are excreted in the urine. A small portion takes another route, in which cytochrome P450 enzymes convert it into a reactive metabolite: N-acetyl-p-benzoquinone imine, NAPQI for short. It is a highly reactive compound, toxic to cells, but under normal conditions it has no chance to do harm, because it is immediately bound by glutathione, the liver's natural antioxidant, and turned into forms the body safely excretes.

The problem begins when the dose is large enough that the glucuronidation and sulphate-conjugation pathways become saturated and more paracetamol goes down the route that leads to NAPQI. Glutathione stores start to run out, and NAPQI, which has nothing left to neutralise it, binds to liver cell proteins, damages mitochondria and leads to hepatocyte necrosis. That is why the antidote works the way it does: N-acetylcysteine, given early, mainly replenishes intracellular glutathione stores, which lets the liver neutralise NAPQI. A review on the evaluation and treatment of paracetamol poisoning stresses that NAC is the cornerstone of treatment and that its benefit is greatest when it is given early.

How should this be interpreted? The study did not show that 4 g a day damages the liver in a clinically perceptible way: it was an asymptomatic rise in an enzyme observed under controlled conditions, and the authors themselves suggested that a history of paracetamol intake should be considered in the work-up of unexplained aminotransferase elevations, even when the blood concentration of the drug cannot be measured. It did show something important for everyday practice, though: the maximum dose is not a value that can be assumed to go 'unnoticed' by the body. In some healthy people the liver responds to it measurably.

The practical conclusion is simple and fits intuition: 4 grams is the upper limit, not a recommended regimen. If pain can be controlled with a smaller dose or for a shorter time, there is no reason to push to the limit. For use longer than a few days, with liver disease, malnutrition or regular alcohol drinking, it is worth having a doctor or pharmacist set the dose, taking into account the state of the liver and other medicines.

This is one of the topics where popular belief runs ahead of evidence. It is commonly repeated that combining paracetamol with alcohol is exceptionally dangerous for the liver, because alcohol induces the enzyme CYP2E1 and increases NAPQI formation. A detailed clinical review, however, shows a more complex picture.

What follows from this? Not that you can stop worrying. The review dates from 2000, it is a narrative review, and the author himself leaves open the possibility that chronic alcohol abuse increases the risk. What does follow is that 'one glass plus a tablet' is not a situation in which the evidence points to high toxicity, and that the problem concerns mainly people who chronically drink large amounts of alcohol, particularly in the first days after stopping. The NIH information page (MedlinePlus) stays cautious: it advises against taking paracetamol if you drink three or more drinks a day, and encourages discussing safe drinking with a doctor during treatment.

We write about the interaction of ibuprofen with alcohol, the other side of the same question 'what should I take for pain after drinking', in a separate article on ibuprofen and alcohol. The two drugs have different risk profiles, so neither is universally 'safer'.

The same review is also a reminder that this is about recommended doses. The result concerns patients in a stable state, not people with acute liver failure or after an overdose. The earlier conclusion from the randomised trial also fits this logic: even in healthy people the maximum dose produces a measurable liver response, so with an already diseased organ caution usually means lower doses and shorter use, set individually. Liver tests, including ALT and AST, are described in our entry on liver function tests.

Intuitively it seems that only swallowing a handful of tablets at once is dangerous. In clinical practice, however, a second, less obvious scenario has been described: a 'staggered' overdose, that is taking doses larger than recommended several times over hours or days, most often in response to pain that will not go away. A person doing this has no sense of self-harm, because they are taking 'ordinary painkillers'.

The practical conclusion: if pain does not ease after the usual dose, do not 'add' more tablets beyond the recommended limit, but consult a doctor or pharmacist. Delayed presentation after an overdose, especially beyond a day, was in this study linked to a worse prognosis. The data come from people who reached a specialist centre with severe liver injury, so they do not show how often such a pattern leads to serious consequences in the population as a whole.

For a single, acute overdose a toxicology review states that for most adults the serious risk of liver injury begins only after taking about 12 g or more, but the history of the time and amount taken is usually unreliable. In people who chronically took excessive doses, liver injury tends to be recognised later, and kidney failure is more common in this group. These figures are not an invitation to a 'safe margin', however: they serve medical staff in assessing risk, not laypeople in planning a dose.

The commonest route to accidentally exceeding the dose is not knowingly swallowing 'too much', but unknowingly combining several products. The NIH information page (MedlinePlus) reminds people to check the labels of all prescription and over-the-counter medicines, because paracetamol is present in many of them. On packaging it is sometimes written in abbreviations such as APAP. The ingredient is especially often found in combination cold and flu products, and taking two products with the same active substance can lead to overdose.

Paracetamol deserves its place as one of the most commonly chosen painkillers: at the right dose it is well tolerated, and for many people with kidney, stomach or circulatory conditions it is a more sensible option than NSAIDs. Its safety, however, rests on one principle: keeping an eye on the total dose. The 4,000 mg a day limit is a ceiling set for healthy adults, and studies show that even at it some bodies respond measurably. The most realistic everyday danger is duplicated combination products and adding tablets when pain does not ease.